Delivery Order SPE2DR25D2012-SPE2DR26F1BHT
- Not listed
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 19, 2025, for the supply of Ondansetron ODT 4 mg tablets in quantities of 30 units. This competitively awarded, non-set-aside contract carries a ceiling value of $8,962.67 under a firm fixed price structure, with an ultimate completion date of August 20, 2025. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 29, 2025, for the supply of Ondansetron ODT 4 mg tablets in a quantity of 30 units, with a ceiling value of $13,637.20. This is a firm fixed-price, non-set-aside delivery order with an ultimate completion date of July 30, 2025, and represents a child contract under AmerisourceBergen's larger federal contract portfolio. AmerisourceBergen Drug Corp, headquartered in...
- The Defense Logistics Agency awarded a delivery order valued at $1,696.19 to AmerisourceBergen Drug Corp for Ondansetron ODT 4 mg tablets (30-count units) on November 17, 2025, with an ultimate completion date of November 18, 2025. This is a firm fixed price, non-set-aside contract for pharmaceutical delivery to support federal medical supply needs. The contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 30, 2025, for the supply of Ondansetron ODT 8 mg tablets in quantities of 30 units. This competitively awarded, non-set-aside contract carries a ceiling value of $4,328.04 under firm fixed-price terms, with an ultimate completion date of July 31, 2025. The pharmaceutical products will be delivered to the contracting location in Conshohocken, Pennsylvania, where...
- The U.S. Defense Department's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 24, 2025, for the supply of Ondansetron ODT 8 mg tablets in quantities of 30 units. The contract is valued at $3,975.60 with a firm fixed price structure and represents a non-set-aside competitive award. Performance will take place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under the company's larger...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 28, 2025, for the supply of Ondansetron ODT 4 mg tablets (30-count) with a contract ceiling value of $9,131.84. This competitively awarded, firm fixed-price delivery order is scheduled for completion by October 29, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract contains no set-aside designation, reflecting the contractor's...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on November 3, 2025, for the supply of Ondansetron ODT 4 mg tablets (30-count units) with a ceiling value of $21,685.95. This is a firm fixed-price delivery order with no set-aside designation, reflecting open competitive procurement. The order is due for completion by November 4, 2025, and will be fulfilled from AmerisourceBergen's facility in Conshohocken, Pennsylvania. This award represents a child...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 16, 2025, for the supply of Ondansetron ODT 4 mg tablets (30-count packages) with a ceiling value of $2,792.28. This is a firm fixed-price delivery order with no set-aside designation, indicating the contract was competitively awarded. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of October 17, 2025. This...
- The Defense Logistics Agency awarded a delivery order valued at $3,430.80 to AmerisourceBergen Drug Corp on August 26, 2025, for the supply of Ondansetron ODT 4 mg tablets in quantities of 30 units. This is a firm fixed price delivery order with no set-aside designation, indicating competitive award. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of August 27, 2025. This delivery order is issued...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 29, 2025, for the supply of Ondansetron ODT 4 mg tablets in quantities of 30, with a contract ceiling value of $13,488.42. This is a firm fixed-price delivery order with no set-aside designation, placing performance at AmerisourceBergen's Conshohocken, Pennsylvania location, and is scheduled for completion by October 30, 2025. The award is issued under AmerisourceBergen's larger Indefinite Delivery...
- SPE2DR25D2012Indefinite Delivery Contract
- SPE2DR25D2012-SPE2DR26F1BHTDelivery Order
The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $12,511.11 on November 3, 2025, for the supply of Ondansetron ODT 4 mg tablets in quantities of 30 units. This is a firm fixed price, competitively awarded contract with no set-aside designation and an ultimate completion date of November 4, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (contract number SPE2DX), a comprehensive global pharmaceutical support vehicle valued at $999,999,999.00 and extending through December 2026. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a critical federal medical procurement vendor with an extensive portfolio of pharmaceutical and medical supply deliveries to military and veteran healthcare systems. The company's federal contracting activity demonstrates consistent capability to fulfill diverse medical supply requirements through competitive procurement, with delivery orders ranging from nominal to substantial values. This particular delivery order for ondansetron, an antiemetic medication commonly used in clinical settings, represents routine pharmaceutical replenishment under the broader IDC framework supporting Defense Health Agency operations and other federal healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $12.5k | 11/3/25 |